We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC OXYCONTIN LAUNCH DELAYED DESPITE FDA APPROVAL
GENERIC OXYCONTIN LAUNCH DELAYED DESPITE FDA APPROVAL
March 26, 2004
The FDA has given generic firms Endo Pharmaceuticals and Teva Pharmaceutical approval to market versions of Purdue Pharma’s powerful pain treatment OxyContin (oxycodone HCl), but ongoing patent litigation has put a hold on the product launches.